ATE391768T1 - Verpackungszelle - Google Patents
VerpackungszelleInfo
- Publication number
- ATE391768T1 ATE391768T1 AT00931647T AT00931647T ATE391768T1 AT E391768 T1 ATE391768 T1 AT E391768T1 AT 00931647 T AT00931647 T AT 00931647T AT 00931647 T AT00931647 T AT 00931647T AT E391768 T1 ATE391768 T1 AT E391768T1
- Authority
- AT
- Austria
- Prior art keywords
- virus
- producing cell
- virus structural
- structural gene
- cell
- Prior art date
Links
- 238000004806 packaging method and process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10051—Methods of production or purification of viral material
- C12N2740/10052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Optical Measuring Cells (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15436499 | 1999-06-01 | ||
| JP2000017831 | 2000-01-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE391768T1 true ATE391768T1 (de) | 2008-04-15 |
Family
ID=26482670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00931647T ATE391768T1 (de) | 1999-06-01 | 2000-06-01 | Verpackungszelle |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6995009B1 (de) |
| EP (1) | EP1186655B1 (de) |
| JP (1) | JP3904451B2 (de) |
| AT (1) | ATE391768T1 (de) |
| AU (1) | AU4952500A (de) |
| DE (1) | DE60038555T2 (de) |
| WO (1) | WO2000073423A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0220467D0 (en) * | 2002-09-03 | 2002-10-09 | Oxford Biomedica Ltd | Composition |
| EP2206724A1 (de) | 2005-12-13 | 2010-07-14 | Kyoto University | Nukleärer Reprogramierungsfaktor |
| US8278104B2 (en) * | 2005-12-13 | 2012-10-02 | Kyoto University | Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2 |
| US8129187B2 (en) | 2005-12-13 | 2012-03-06 | Kyoto University | Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2 |
| US20090227032A1 (en) | 2005-12-13 | 2009-09-10 | Kyoto University | Nuclear reprogramming factor and induced pluripotent stem cells |
| JP2008307007A (ja) * | 2007-06-15 | 2008-12-25 | Bayer Schering Pharma Ag | 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞 |
| US9213999B2 (en) | 2007-06-15 | 2015-12-15 | Kyoto University | Providing iPSCs to a customer |
| JP5346925B2 (ja) | 2008-05-02 | 2013-11-20 | 国立大学法人京都大学 | 核初期化方法 |
| JP5988961B2 (ja) | 2010-04-28 | 2016-09-07 | ザ ジェイ. デヴィッド グラッドストーン インスティテューツ | 心筋細胞を発生させるための方法 |
| WO2016164371A1 (en) | 2015-04-07 | 2016-10-13 | The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone | Methods for inducing cell division of postmitotic cells |
| GB201509040D0 (en) * | 2015-05-27 | 2015-07-08 | Oxford Genetics Ltd | Cell lines |
| WO2018075623A1 (en) | 2016-10-19 | 2018-04-26 | The J. David Gladstone Institutes, A Testamentary Trust Etablished Under The Will Of J. David Gladst | Genetically encoded cell death indicators and methods of use |
| KR20210102870A (ko) | 2018-08-30 | 2021-08-20 | 테나야 테라퓨틱스, 인코포레이티드 | 미오카르딘 및 ascl1을 사용한 심장 세포 재프로그래밍 |
| CN114450411A (zh) | 2019-04-01 | 2022-05-06 | 特纳亚治疗股份有限公司 | 具有工程化衣壳的腺相关病毒 |
| EP3997226A1 (de) | 2019-07-11 | 2022-05-18 | Tenaya Therapeutics, Inc. | Umprogrammierung von herzzellen mit mikrornas und anderen faktoren |
| CN115552022A (zh) | 2020-03-02 | 2022-12-30 | 特纳亚治疗股份有限公司 | 由心肌细胞表达的微rna控制的基因载体 |
| JP7415042B2 (ja) | 2020-10-09 | 2024-01-16 | テナヤ セラピューティクス, インコーポレイテッド | プラコフィリン2遺伝子治療の方法および組成物 |
| US11781156B2 (en) | 2020-10-09 | 2023-10-10 | Tenaya Therapeutics, Inc. | Plakophillin-2 gene therapy methods and compositions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2751345B1 (fr) * | 1996-07-16 | 1998-09-18 | Univ Paris Curie | Lignees d'encapsidation hautement productrices |
| FR2779445B1 (fr) * | 1998-06-08 | 2000-08-11 | Univ Nantes | Kit d'encapsidation |
-
2000
- 2000-06-01 WO PCT/JP2000/003557 patent/WO2000073423A1/ja not_active Ceased
- 2000-06-01 EP EP00931647A patent/EP1186655B1/de not_active Expired - Lifetime
- 2000-06-01 US US10/009,329 patent/US6995009B1/en not_active Expired - Lifetime
- 2000-06-01 JP JP2001500738A patent/JP3904451B2/ja not_active Expired - Lifetime
- 2000-06-01 AT AT00931647T patent/ATE391768T1/de not_active IP Right Cessation
- 2000-06-01 DE DE60038555T patent/DE60038555T2/de not_active Expired - Lifetime
- 2000-06-01 AU AU49525/00A patent/AU4952500A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE60038555T2 (de) | 2009-06-10 |
| AU4952500A (en) | 2000-12-18 |
| EP1186655A1 (de) | 2002-03-13 |
| JP3904451B2 (ja) | 2007-04-11 |
| EP1186655B1 (de) | 2008-04-09 |
| WO2000073423A1 (en) | 2000-12-07 |
| DE60038555D1 (de) | 2008-05-21 |
| EP1186655A4 (de) | 2003-04-09 |
| US6995009B1 (en) | 2006-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60038555D1 (de) | Verpackungszelle | |
| Lee et al. | Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles | |
| Jayakar et al. | Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release | |
| NO995382L (no) | Lentivirus baserte genoverfoeringsvektorer | |
| Zufferey et al. | Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors | |
| Blumberg et al. | Sequence determination of the Sendai virus fusion protein gene | |
| Gorchakov et al. | Selection of functional 5′ cis-acting elements promoting efficient Sindbis virus genome replication | |
| Gorchakov et al. | A new role for ns polyprotein cleavage in Sindbis virus replication | |
| Masters | Localization of an RNA-binding domain in the nucleocapsid protein of the coronavirus mouse hepatitis virus | |
| ATE451835T1 (de) | Therapeutische verfahren und zusammensetzungen unter verwendung von viren der rekombinanten familie der paramyxoviridae | |
| ATE460490T1 (de) | Erhöhte expression von transgenen durch co- exprimierung mit einen suppressor der post- transkriptionelle genabschaltung (ptgs) | |
| DK1276876T3 (da) | Ekspressionsregulerende sekvenser fra den filamentöse svamp Chrysosporium | |
| KR920021706A (ko) | 제조 합형 아비폭스 바이러스, 이 바이러스에 의하여 감염된 세포의 배양, 이 바이러스로부터 유도된 가금용 왁찐 | |
| Kulasegaran-Shylini et al. | Structural and functional elements of the promoter encoded by the 5′ untranslated region of the Venezuelan equine encephalitis virus genome | |
| Baker et al. | Encapsidation of Sendai virus genome RNAs by purified NP protein during in vitro replication | |
| Bachrach et al. | Animal picornaviruses with a single major species of capsid protein | |
| ES2300105T3 (es) | Vectores adenoviricos para terapia genica. | |
| Pugachev et al. | Effects of defined mutations in the 5′ nontranslated region of rubella virus genomic RNA on virus viability and macromolecule synthesis | |
| Larson et al. | Reovirus exists in the form of 13 particle species that differ in their content of protein σ1 | |
| Graveley et al. | A common mechanism for the enhancement of mRNA 3'processing by U3 sequences in two distantly related lentiviruses | |
| CA2268353A1 (en) | Alphavirus-retrovirus vectors | |
| Pugachev et al. | Development of a rubella virus vaccine expression vector: use of a picornavirus internal ribosome entry site increases stability of expression | |
| Gupta et al. | Translational modulation Invitro of a eukaryotic viral mRNA encoding overlapping genes: Ribosome scanning and potential roles of conformational changes in the PC mRNA of sendai virus | |
| Ruis et al. | Genome structure and expression of the ev/J family of avian endogenous viruses | |
| Jayan et al. | Effects of conserved RNA secondary structures on hepatitis delta virus genotype I RNA editing, replication, and virus production |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |